NCT00389480View on ClinicalTrials.gov

Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

May 31, 2009

Conditions
Tumors
Interventions
DRUG

AR-67 (formerly DB-67)

infusion daily x 5 days, every 21 days

Trial Locations (2)

40536

University of Kentucky, Lexington

63141

Arch Medical Services Inc. DBA The Center for Cancer Care and Research, St Louis

Sponsors

Lead Sponsor

Arno Therapeutics
All Listed Sponsors
collaborator

University of Kentucky

OTHER

collaborator

Arch Medical Services Inc., DBA The Center for Cancer Care and Research

INDUSTRY

lead

Arno Therapeutics

INDUSTRY

NCT00389480 - Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies | Biotech Hunter | Biotech Hunter